Debt-to-equity improved from 3.34 in 2024Q4 to 1.83 in 2026Q3 largely through equity rebuilding, while total debt stayed in a $94B to $108B band, indicating leverage remains elevated against $13.4B of cash.
Suzano S.A. (SUZ) balance sheet — 21-year assets, liabilities & shareholders' equity history
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 |
|---|
| Total Current Assets | 48.21B | 43.85B | 42.18B | 38.57B | 37.12B | 34.1B | 3.46B | 4.69B | 30.8B | 6.8B | 8.03B | 6.59B | 6.61B | 6.47B | 6.69B | 5.37B | 5.42B | 4.15B | 4.41B | 3.11B | 2.98B | 2.42B |
| Cash & Short-Term Investments | 21.19B | 25.1B | 21.99B | 21.17B | 17.05B | 21.1B | 1.74B | 2.34B | 25.49B | 2.71B | 3.7B | 2.45B | 3.69B | 3.69B | 4.34B | 3.27B | 3.74B | 2.53B | 2.18B | 1.33B | 1.5B | 1.08B |
| Cash Only | 13.41B | 15.17B | 9.02B | 8.35B | 9.51B | 13.59B | 1.32B | 807.7M | 4.39B | 1.08B | 1.61B | 1.48B | 3.69B | 3.69B | 4.34B | 3.27B | 3.74B | 2.53B | 2.18B | 1.33B | 1.5B | 1.08B |
| Short-Term Investments | 7.78B | 9.93B | 12.97B | 12.82B | 7.55B | 7.51B | 425.87M | 1.53B | 21.1B | 1.63B | 2.08B | 970.85M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 10.47B | 8.96B | 10.24B | 7.74B | 10.16B | 6.9B | 781.83M | 1.09B | 2.54B | 2.3B | 2.16B | 1.89B | 1.21B | 1.47B | 1.16B | 1.39B | 845.48M | 1B | -9.29M | -17.31M | 764.59M | 714.14M |
| Days Sales Outstanding | 61.66 | 66.57 | 78.87 | 71.03 | 74.45 | 61.47 | 9.37 | 15.24 | 68.88 | 79.72 | 79.81 | 67.33 | 60.66 | 94.59 | 81.86 | 104.88 | 68.37 | 92.63 | - | - | 90.05 | 93.53 |
| Inventory | 10.83B | 8.23B | 7.96B | 5.95B | 5.73B | 4.64B | 780.2M | 1.21B | 1.85B | 1.21B | 1.31B | 1.32B | 1.08B | 905.26M | 683.75M | 722.4M | 658.82M | 605.66M | 881.57M | 695.46M | 576.07M | 463.07M |
| Days Inventory Outstanding | 85.4 | 88.74 | 106.06 | 86.56 | 84.23 | 82.11 | 15.01 | 21.24 | 97.71 | 68.36 | 72.93 | 77.67 | 73.41 | 78.85 | 61.83 | 69.9 | 76.38 | 72.65 | 121.55 | 114.13 | 107.8 | 95.82 |
| Other Current Assets | 5.6B | 1.56B | 1.9B | 3.6B | 4.07B | 1.41B | 153.51M | 64.7M | 922.71M | 595.72M | 894.73M | 901.82M | 620.5M | 393.96M | 192.8M | 16.68M | 171.75M | 1.08B | 1.35B | 1.11B | 134.63M | 153.72M |
| Total Non-Current Assets | 142.38B | 124.01B | 123.75B | 105.02B | 96.08B | 84.87B | 16.14B | 19.64B | 23.13B | 21.73B | 21.37B | 21.67B | 21.51B | 20.68B | 18.67B | 16.28B | 13.49B | 8.61B | 8.55B | 8.34B | 7.18B | 4.9B |
| Property, Plant & Equipment | 80.56B | 95.68B | 70.17B | 64.49B | 55.77B | 42.96B | 10.52B | 13.81B | 17.02B | 16.21B | 16.24B | 16.35B | 16.68B | 16.55B | 15.15B | 13.07B | 10.94B | 6.96B | 6.88B | 6.81B | 5.94B | 4.09B |
| Fixed Asset Turnover | 0.62x | 0.51x | 0.68x | 0.62x | 0.89x | 0.95x | 2.89x | 1.88x | 0.79x | 0.65x | 0.61x | 0.63x | 0.44x | 0.34x | 0.34x | 0.37x | 0.41x | 0.57x | 0.59x | 0.50x | 0.52x | 0.68x |
| Goodwill | 9.95B | 8.18B | 8.42B | 8.42B | 8.25B | 8.25B | 1.54B | 2B | 158.33M | 45.45M | 45.45M | 45.45M | 79.49M | 34.06M | 34.06M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 7.27B | 4.78B | 5.71B | 6.56B | 7.17B | 8.01B | 1.68B | 2.4B | 181.51M | 142.98M | 174.14M | 284.18M | 212.58M | 190.53M | 178.68M | 1.39B | 845.48M | 1B | -9.29M | -17.31M | 0 | 0 |
| Long-Term Investments | 23.06B | 9.94B | 1.59B | 379.13M | 379.12M | 292.32M | 364.71M | 457.01M | 14.34M | 6.76M | 873K | 800.36M | 816.65M | 872.95M | 606.28M | 0 | 0 | 590.64M | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 42.3B | 3.92B | 29.88B | 24.64B | 20.52B | 16.62B | 356.11M | 446.48M | 5.75B | 5.32B | 4.91B | 4.19B | 3.72B | 3.03B | 2.7B | 3.01B | 2.38B | 55.46M | 526.89M | 1.01B | 1.08B | 677.19M |
| Total Assets | 190.59B | 167.85B | 165.94B | 143.59B | 133.2B | 118.98B | 19.6B | 24.34B | 53.93B | 28.52B | 29.4B | 28.26B | 28.12B | 27.15B | 25.35B | 21.66B | 18.91B | 12.76B | 12.96B | 11.46B | 10.16B | 7.32B |
| Asset Turnover | 0.30x | 0.29x | 0.29x | 0.28x | 0.37x | 0.34x | 1.55x | 1.07x | 0.25x | 0.37x | 0.34x | 0.36x | 0.26x | 0.21x | 0.20x | 0.22x | 0.24x | 0.31x | 0.31x | 0.30x | 0.31x | 0.38x |
| Asset Growth % | 31.01% | 1.15% | 15.56% | 7.8% | 11.95% | 507.05% | -19.48% | -54.87% | 89.08% | -2.98% | 4.03% | 0.5% | 3.57% | 7.08% | 17.07% | 14.51% | 48.24% | -1.54% | 13.11% | 12.76% | 38.8% | - |
| Total Current Liabilities | 19.01B | 13.77B | 24.48B | 14.8B | 14.49B | 11.55B | 1.57B | 2.85B | 6.06B | 3.71B | 3.83B | 3.51B | 3.07B | 2.28B | 2.86B | 3.08B | 2.08B | 2.14B | 2.36B | 1.34B | 996.55M | 1.44B |
| Accounts Payable | 8.73B | 5.14B | 6.03B | 5.57B | 6.21B | 3.29B | 454.56M | 590.76M | 632.57M | 621.18M | 582.92M | 581.48M | 501.56M | 876.56M | 1.02B | 548.7M | 325.45M | 316.13M | 332.14M | 473.52M | 253.44M | 231.87M |
| Days Payables Outstanding | 57.24 | 55.42 | 80.37 | 81.11 | 91.27 | 58.23 | 8.75 | 10.39 | 33.35 | 35.15 | 32.38 | 34.32 | 34.18 | 76.35 | 91.87 | 53.1 | 37.73 | 37.92 | 45.8 | 77.71 | 47.42 | 47.98 |
| Short-Term Debt | 4.64B | 2.34B | 10.5B | 4.76B | 3.34B | 3.66B | 332.79M | 1.49B | 3.42B | 2.11B | 1.59B | 2.02B | 1.79B | 995.59M | 1.59B | 2.28B | 1.38B | 1.46B | 1.74B | 748.4M | 585.29M | 1.01B |
| Deferred Revenue (Current) | 376.5M | 132.34M | 145.2M | 172.44M | 131.35M | 103.66M | 4.85M | 14.91M | 75.16M | 92.55M | 514.77M | 32.06M | 7.82M | 7.43M | 11.55M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 2.4B | 3.39B | 3.13B | 1.01B | 3.02B | 2.03B | 667.05M | 597.94M | 1.77B | 775.65M | 1.49B | 722.01M | 614.08M | 218.06M | 24.56M | -28.92M | 91.1M | 35.77M | 95.19M | -24.24M | 59.62M | 55.08M |
| Current Ratio | 2.54x | 3.19x | 1.72x | 2.61x | 2.56x | 2.95x | 2.20x | 1.65x | 5.08x | 1.83x | 2.10x | 1.88x | 2.15x | 2.84x | 2.34x | 1.74x | 2.61x | 1.94x | 1.87x | 2.32x | 2.99x | 1.68x |
| Quick Ratio | 1.97x | 2.59x | 1.40x | 2.20x | 2.17x | 2.55x | 1.70x | 1.22x | 4.78x | 1.51x | 1.75x | 1.50x | 1.80x | 2.44x | 2.10x | 1.51x | 2.30x | 1.66x | 1.50x | 1.80x | 2.41x | 1.36x |
| Cash Conversion Cycle | 89.83 | 99.89 | 104.56 | 76.49 | 67.41 | 85.34 | 15.64 | 26.08 | 133.24 | 112.92 | 120.37 | 110.68 | 99.89 | 97.09 | 51.82 | 121.69 | 107.01 | 127.36 | - | - | 150.43 | 141.37 |
| Total Non-Current Liabilities | 114.13B | 110.16B | 109.04B | 83.99B | 85.54B | 92.25B | 16.61B | 16.99B | 35.85B | 13.19B | 15.43B | 15.56B | 14.74B | 14.18B | 11.5B | 8.9B | 8.2B | 6.24B | 6.87B | 5.72B | 5.15B | 2.77B |
| Long-Term Debt | 93.2B | 97.82B | 90.93B | 72.41B | 71.24B | 75.97B | 13.64B | 14.25B | 32.3B | 10.06B | 12.4B | 12.87B | 11.94B | 11.85B | 9.24B | 6.56B | 5.77B | 5.26B | 5.9B | 4.9B | 4.86B | 2.55B |
| Capital Lease Obligations | 23.91B | 6.07B | 6.1B | 5.49B | 5.51B | 5.27B | 880.13M | 827.11M | 12.62M | 15.05M | 18.84M | 27.11M | 21.69M | 20.92M | 27.74M | 54.53M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 6.34B | 0 | 12.6M | 11.38M | 1.12M | 0 | 109.74K | 143.9M | 1.04B | 1.79B | 1.56B | 1.04B | 1.48B | 1.63B | 1.68B | 0 | 0 | 334.24M | 0 | -4.36B | -4.05B | -1.33B |
| Other Non-Current Liabilities | 10.85B | 6.19B | 11.92B | 6B | 8.65B | 10.86B | 2.09B | 1.77B | 3.54B | 2.29B | 609.11M | 2.66B | 2.39B | 2.06B | 289.28M | 447.19M | 2.42B | 12.85M | 966.99M | 820.82M | 260.33M | 202.71M |
| Total Liabilities | 133.14B | 123.92B | 133.52B | 98.78B | 100.03B | 103.8B | 18.19B | 19.84B | 41.91B | 16.9B | 19.26B | 19.07B | 17.8B | 16.46B | 14.35B | 11.98B | 10.27B | 8.38B | 9.22B | 7.07B | 6.15B | 4.21B |
| Total Debt | 104.97B | 106.22B | 108.41B | 83.42B | 80.76B | 85.52B | 14.85B | 16.57B | 35.74B | 12.19B | 14.01B | 15.54B | 14.48B | 13.05B | 10.9B | 7.89B | 7.16B | 6.72B | 7.64B | 5.64B | 5.44B | 3.56B |
| Net Debt | 91.56B | 91.05B | 99.39B | 75.07B | 71.25B | 71.93B | 13.54B | 15.76B | 31.35B | 11.12B | 12.4B | 14.06B | 10.79B | 9.37B | 6.56B | 4.61B | 3.42B | 4.19B | 5.46B | 4.31B | 3.94B | 2.47B |
| Debt / Equity | 1.83x | 2.42x | 3.34x | 1.86x | 2.43x | 5.64x | 10.52x | 3.68x | 2.97x | 1.05x | 1.38x | 1.69x | 1.40x | 1.22x | 0.99x | 0.82x | 0.83x | 1.53x | 2.04x | 1.28x | 1.36x | 1.14x |
| Debt / EBITDA | 5.08x | 4.72x | 4.35x | 4.27x | 2.72x | 3.39x | 0.98x | 1.55x | 5.44x | 2.62x | 5.15x | 3.46x | 5.92x | 6.83x | 8.57x | 14.84x | 5.02x | 6.10x | - | 4.04x | 5.52x | 3.76x |
| Net Debt / EBITDA | 4.43x | 4.05x | 3.99x | 3.84x | 2.40x | 2.85x | 0.89x | 1.48x | 4.77x | 2.38x | 4.56x | 3.13x | 4.41x | 4.90x | 5.16x | 8.68x | 2.40x | 3.80x | - | 3.09x | 4.00x | 2.62x |
| Interest Coverage | 2.37x | 4.06x | 2.97x | 5.41x | 7.13x | 3.36x | -16.20x | -0.44x | 1.00x | 2.74x | 4.58x | -0.17x | 0.85x | 0.69x | 0.46x | 0.80x | 4.29x | - | 2.25x | 3.43x | 3.20x | 3.78x |
| Total Equity | 57.45B | 43.93B | 32.42B | 44.81B | 33.17B | 15.18B | 1.41B | 4.5B | 12.03B | 11.62B | 10.14B | 9.19B | 10.32B | 10.69B | 11B | 9.67B | 8.64B | 4.38B | 3.74B | 4.39B | 4.01B | 3.11B |
| Equity Growth % | 102.51% | 35.52% | -27.66% | 35.11% | 118.56% | 974.26% | -68.58% | -62.61% | 3.48% | 14.57% | 10.35% | -10.89% | -3.48% | -2.86% | 13.73% | 11.95% | 97.11% | 17.32% | -14.91% | 9.42% | 29.07% | - |
| Book Value per Share | 46.53 | 35.44 | 25.63 | 34.53 | 24.93 | 11.24 | 1.05 | 3.33 | 10.98 | 10.62 | 9.31 | 8.45 | 9.46 | 9.82 | 15.24 | 20.53 | 23.67 | 11.44 | 8.73 | 11.22 | 13.29 | 10.30 |
| Total Shareholders' Equity | 51.63B | 43.79B | 32.28B | 44.69B | 33.06B | 15.08B | 1.39B | 4.47B | 12.01B | 11.62B | 10.14B | 9.19B | 10.32B | 10.69B | 11B | 9.67B | 8.64B | 4.38B | 3.74B | 4.39B | 4.01B | 3.11B |
| Common Stock | 24.25B | 24.22B | 19.27B | 9.24B | 9.24B | 9.24B | 1.78B | 2.3B | 6.24B | 6.24B | 6.24B | 6.24B | 6.24B | 6.24B | 6.24B | 3.45B | 2.69B | 2.05B | 2.05B | 2.05B | 2.05B | 1.48B |
| Retained Earnings | 8.28B | 0 | 12.98B | 0 | 24.21B | 3.93B | -755.85M | 0 | 2.99B | 2.92B | 1.64B | 706.14M | 1.85B | 2.19B | 2.47B | 0 | 0 | 0 | 1.47B | 0 | 0 | 0 |
| Treasury Stock | -1.69B | -1.51B | -1.34B | -1.48B | -2.12B | -218.26M | -42.02M | -54.26M | -218.26M | -241.09M | -273.67M | -288.86M | -303.73M | -312.24M | 0 | 0 | 0 | 0 | -201.8M | -15.08M | 0 | 0 |
| Accumulated OCI | 20.79B | 21.08B | 1.38B | 36.94B | 25.95B | 2.13B | 412.11M | 2.23B | 3B | 3.32B | 1.86B | 500.25M | 1.63B | 1.95B | 2.26B | -3.94B | -4.06B | -3.71B | -3.39B | -3.03B | -2.8B | 0 |
| Minority Interest | 5.82B | 140.06M | 131.31M | 117.53M | 105.33M | 99.66M | 20.32M | 28.67M | 13.93M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying SUZ stock.
As of 2025, Suzano S.A. (SUZ) had total assets of $167.85B including $43.85B in current assets.
Suzano S.A. (SUZ) carries total debt of $106.22B, offset by $25.10B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Suzano S.A. (SUZ) has total shareholders' equity (book value) of $43.79B ($35.44 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Suzano S.A. (SUZ) reported a current ratio of 3.19x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.
Key Metrics
Top Statement Risk
Leverage amplifies pulp price exposure
Leverage Easing From Peak but Still Elevated
Based on Suzano's reported figures, debt-to-equity fell from 3.34 in 2024Q4 to 1.83 in 2026Q3 as equity rebuilt, though the ratio remains well above conservative levels for a cyclical pulp producer.
The improvement is driven mainly by equity recovery from retained earnings swinging from losses in 2024 to $8.3B in 2026Q3, not by a material reduction in gross debt, which stayed near $97B to $105B throughout the period. This suggests deleveraging has been earnings-dependent rather than structurally funded, and investors should monitor whether earnings hold up if pulp prices soften again. Total liabilities still exceed $130B against a roughly $52B equity base, indicating limited balance sheet cushion.
Debt Stable While Equity Carries Adjustment
According to reported quarterly balance sheets, total debt has held in a $94B to $108B band across ten quarters, meaning leverage improvement has come almost entirely from the denominator rather than debt reduction.
Debt levels have remained structurally high relative to the cash generation implied by thin recent free cash flow margins of 8.7% in 2026Q3 and negative in 2026Q1. This implies refinancing and interest burden remain a persistent claim on operating cash, which may constrain flexibility if pulp prices remain weak. The reported figures do not disclose debt maturity or currency composition, so refinancing risk warrants further investigation.
Current Ratio Recovered but Cash Thin
As reported in the financial statements, Suzano's current ratio rebounded to 2.54 in 2026Q3 from 1.72 in 2024Q4, while cash of $13.4B sits well below total debt of $105B.
The recovery in the current ratio suggests improved short-term asset coverage, though cash alone covers only about 13% of total debt, meaning liquidity depends on continued operating cash inflows and access to credit. Cash balances have moved between $5.8B and $16.6B over the period, a range that offers a modest buffer against a sustained pricing shock. Investors should treat the liquidity profile as adequate rather than robust.
Asset Base Anchored by Forestry and Mills
Based on reported figures, net PP&E rose to $80.6B in 2026Q3 from roughly $70B through 2024 and 2025, with total assets reaching $190.6B, indicating a capital-intensive asset mix.
The asset base reflects the capital intensity of the eucalyptus plantations and industrial pulp mills, consistent with an asset-heavy business model. The step-up in PP&E aligns with mill project spending, which supports long-run productive capacity but also raises the fixed-cost burden if demand softens. Goodwill is modest at roughly $8B to $10B relative to total assets, so impairment risk appears limited compared to the tangible asset base.
Equity Rebuild May Overstate Balance Sheet Repair
Based on reported figures, equity growth from $32.3B to $51.6B may reflect non-cash earnings swings rather than durable cash generation, which the debt-to-equity improvement could overstate.
Retained earnings moved from losses to $26.4B in 2025Q3 and then back to zero in 2025Q4, a volatility that suggests reported equity is sensitive to non-operating and non-cash items, including biological asset fair value adjustments and foreign exchange effects. This pattern implies the apparent deleveraging could reverse quickly if these items turn unfavorable. Investors should treat the improved leverage ratio as provisional until cash-based metrics confirm it.